Jason Cassorla
Stock Analyst at Citigroup
(1.91)
# 2,932
Out of 4,786 analysts
40
Total ratings
50%
Success rate
-0.96%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason Cassorla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACS PACS Group | Reinstates: Buy | $45 | $11.24 | +300.36% | 3 | Sep 11, 2024 | |
| SGRY Surgery Partners | Maintains: Buy | $38 → $36 | $23.75 | +51.58% | 6 | Aug 7, 2024 | |
| THC Tenet Healthcare | Maintains: Buy | $139 → $171 | $134.50 | +27.14% | 7 | Jul 25, 2024 | |
| UHS Universal Health Services | Maintains: Buy | $170 → $193 | $187.90 | +2.71% | 5 | Feb 29, 2024 | |
| HCA HCA Healthcare | Maintains: Buy | $324 → $279 | $345.55 | -19.26% | 5 | Oct 25, 2023 | |
| CLOV Clover Health Investments | Maintains: Neutral | $1 → $1.5 | $3.59 | -58.22% | 3 | Aug 11, 2023 | |
| CYH Community Health Systems | Maintains: Buy | $9 → $7 | $2.70 | +159.26% | 8 | May 3, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $16 → $18 | $8.79 | +104.78% | 2 | Feb 17, 2023 | |
| INNV InnovAge Holding | Maintains: Neutral | $5 → $8 | $2.98 | +168.46% | 1 | Nov 16, 2022 |
PACS Group
Sep 11, 2024
Reinstates: Buy
Price Target: $45
Current: $11.24
Upside: +300.36%
Surgery Partners
Aug 7, 2024
Maintains: Buy
Price Target: $38 → $36
Current: $23.75
Upside: +51.58%
Tenet Healthcare
Jul 25, 2024
Maintains: Buy
Price Target: $139 → $171
Current: $134.50
Upside: +27.14%
Universal Health Services
Feb 29, 2024
Maintains: Buy
Price Target: $170 → $193
Current: $187.90
Upside: +2.71%
HCA Healthcare
Oct 25, 2023
Maintains: Buy
Price Target: $324 → $279
Current: $345.55
Upside: -19.26%
Clover Health Investments
Aug 11, 2023
Maintains: Neutral
Price Target: $1 → $1.5
Current: $3.59
Upside: -58.22%
Community Health Systems
May 3, 2023
Maintains: Buy
Price Target: $9 → $7
Current: $2.70
Upside: +159.26%
Enhabit
Feb 17, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $8.79
Upside: +104.78%
InnovAge Holding
Nov 16, 2022
Maintains: Neutral
Price Target: $5 → $8
Current: $2.98
Upside: +168.46%